Media release
From:
JAMA
COVID-19 and Cognitive Change in a Community-Based Cohort
About The Study: This cohort study of older participants found accelerated decreases in cognition among individuals hospitalized for SARS-CoV-2 infection, but not nonhospitalized infection, in comparison with individuals not yet infected. These findings suggest that avoiding severe SARS-CoV-2 infection could help preserve cognitive function among older adults.
Journal/
conference:
JAMA Network Open
Organisation/s:
Mayo Clinic, USA, Columbia University Irving Medical Center, USA
Funder:
The C4R study is supported by the NHLBI–Collaborating Network of Networks for Evaluating
COVID-19 and Therapeutic Strategies (grant No. OT2HL156812), with cofunding from the NINDS and the NIA. The
Atherosclerosis Risk in Communities Study has been funded in whole or in part by the NHLBI, the NIH, and US
Department of Health and Human Services (contracts 75N92022D00001, 75N92022D00002,
75N92022D00003, 75N92022D00004, and 75N92022D00005). Neurocognitive data were collected under
grants from the NHLBI, the NINDS, the NIA, and the National Institute on Deafness and Other Communication
Disorders (grant Nos. U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, and
2U01HL096917). Ancillary studies funded additional data elements. The Blood Pressure and Cognition Study is
supported by the NINDS (grant R01 NS102715).